Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2020

01-12-2020 | Systemic Lupus Erythematosus | Research article

Cerebral microvascular and microstructural integrity is regionally altered in patients with systemic lupus erythematosus

Authors: Mark W. DiFrancesco, Gregory Lee, Mekibib Altaye, Dean W. Beebe, Jamie Meyers-Eaton, Hermine I. Brunner

Published in: Arthritis Research & Therapy | Issue 1/2020

Login to get access

Abstract

Background

To measure regional brain microvascular and microstructural changes in childhood-onset SLE (cSLE) using diffusion-weighted imaging (DWI) at multiple b values and investigate relationships of those measures with neurocognitive function and disease activity.

Methods

In this cross-sectional, case-control study, vascular volume fraction, effective diffusion, parenchymal diffusion, and blood flow parameters were regionally compared in cSLE patients and matched healthy controls. These markers of microvascular and microstructural integrity were derived by diffusion-weighted brain MRI and intravoxel incoherent motion (IVIM) modeling. Formal neurocognitive testing was completed focused on the domains of attention, visuoconstructional ability, working memory, and psychomotor speed. Test scores and measures of disease severity were regressed against regional microvascular integrity parameters among cSLE patients.

Results

Formal cognitive testing confirmed normal cognitive ability among all cSLE patients included in the analysis (n = 11). Nevertheless, reduction in blood volume fraction coincided with increased effective diffusion and flow parameters in cSLE patients vs. controls in posterior brain regions including the cuneus and precuneus. Regional microvascular measures correlated (|r| = 0.54–0.66) with neuropsychiatric scores and disease activity among cSLE patients.

Conclusions

There is imaging evidence, using IVIM, of degraded microvascular integrity in cSLE patients with normal cognitive ability. The observed regional changes correspond with posterior vascular border zones. These outcomes appear consistent with regional gray matter volume loss previously observed in cSLE patients with overt neurocognitive deficits, supporting the notion that adverse vascular changes precede loss of cognitive ability in cSLE. Longitudinal studies are needed to confirm the findings of this initial study.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sibbitt WL Jr, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, Bankhurst AD, Brooks WM. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002;29(7):1536–42.PubMed Sibbitt WL Jr, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, Bankhurst AD, Brooks WM. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002;29(7):1536–42.PubMed
2.
go back to reference Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol. 1995;34(9):866–72.CrossRef Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol. 1995;34(9):866–72.CrossRef
3.
go back to reference Legendre P, Regent A, Thiebault M, Mouthon L. Anti-endothelial cell antibodies in vasculitis: a systematic review. Autoimmun Rev. 2017;16(2):146–53.CrossRef Legendre P, Regent A, Thiebault M, Mouthon L. Anti-endothelial cell antibodies in vasculitis: a systematic review. Autoimmun Rev. 2017;16(2):146–53.CrossRef
4.
go back to reference Scolding NJ, Joseph FG. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol Appl Neurobiol. 2002;28(3):173–89.CrossRef Scolding NJ, Joseph FG. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol Appl Neurobiol. 2002;28(3):173–89.CrossRef
5.
go back to reference Chi JM, Mackay M, Hoang A, Cheng K, Aranow C, Ivanidze J, Volpe B, Diamond B, Sanelli PC. Alterations in blood-brain barrier permeability in patients with systemic lupus erythematosus. AJNR Am J Neuroradiol. 2019;40(3):470–7.PubMedPubMedCentral Chi JM, Mackay M, Hoang A, Cheng K, Aranow C, Ivanidze J, Volpe B, Diamond B, Sanelli PC. Alterations in blood-brain barrier permeability in patients with systemic lupus erythematosus. AJNR Am J Neuroradiol. 2019;40(3):470–7.PubMedPubMedCentral
6.
go back to reference Gulati G, Jones JT, Lee G, Altaye M, Beebe DW, Meyers-Eaton J, Wiley K, Brunner HI, DiFrancesco MW. Altered blood-brain barrier permeability in patients with systemic lupus erythematosus: a novel imaging approach. Arthritis Care Res (Hoboken). 2017;69(2):299–305.CrossRef Gulati G, Jones JT, Lee G, Altaye M, Beebe DW, Meyers-Eaton J, Wiley K, Brunner HI, DiFrancesco MW. Altered blood-brain barrier permeability in patients with systemic lupus erythematosus: a novel imaging approach. Arthritis Care Res (Hoboken). 2017;69(2):299–305.CrossRef
7.
go back to reference Abbott NJ, Mendonca LL, Dolman DE. The blood-brain barrier in systemic lupus erythematosus. Lupus. 2003;12(12):908–15.CrossRef Abbott NJ, Mendonca LL, Dolman DE. The blood-brain barrier in systemic lupus erythematosus. Lupus. 2003;12(12):908–15.CrossRef
8.
go back to reference Stock AD, Gelb S, Pasternak O, Ben-Zvi A, Putterman C. The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface. Autoimmun Rev. 2017;16(6):612–9.CrossRef Stock AD, Gelb S, Pasternak O, Ben-Zvi A, Putterman C. The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface. Autoimmun Rev. 2017;16(6):612–9.CrossRef
9.
go back to reference Jia J, Xie J, Li H, Wei H, Li X, Hu J, Meng D, Zhang Y, Zhang X. Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus. Lupus. 2019;28(9):1128–33.CrossRef Jia J, Xie J, Li H, Wei H, Li X, Hu J, Meng D, Zhang Y, Zhang X. Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus. Lupus. 2019;28(9):1128–33.CrossRef
10.
go back to reference Wang PI, Cagnoli PC, McCune WJ, Schmidt-Wilcke T, Lowe SE, Graft CC, Gebarski SS, Chenevert TL, Khalatbari S, Myles JD, Watcharotone K, Cronin P, Sundgren PC. Perfusion-weighted MR imaging in cerebral lupus erythematosus. Acad Radiol. 2012;19(8):965–70.CrossRef Wang PI, Cagnoli PC, McCune WJ, Schmidt-Wilcke T, Lowe SE, Graft CC, Gebarski SS, Chenevert TL, Khalatbari S, Myles JD, Watcharotone K, Cronin P, Sundgren PC. Perfusion-weighted MR imaging in cerebral lupus erythematosus. Acad Radiol. 2012;19(8):965–70.CrossRef
11.
go back to reference Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.CrossRef Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.CrossRef
12.
go back to reference DiFrancesco MW, Gitelman DR, Klein-Gitelman MS, Sagcal-Gironella AC, Zelko F, Beebe D, Parrish T, Hummel J, Ying J, Brunner HI. Functional neuronal network activity differs with cognitive dysfunction in childhood-onset systemic lupus erythematosus. Arthritis Res Ther. 2013;15(2):R40.CrossRef DiFrancesco MW, Gitelman DR, Klein-Gitelman MS, Sagcal-Gironella AC, Zelko F, Beebe D, Parrish T, Hummel J, Ying J, Brunner HI. Functional neuronal network activity differs with cognitive dysfunction in childhood-onset systemic lupus erythematosus. Arthritis Res Ther. 2013;15(2):R40.CrossRef
13.
go back to reference DiFrancesco MW, Holland SK, Ris MD, Adler CM, Nelson S, DelBello MP, Altaye M, Brunner HI. Functional magnetic resonance imaging assessment of cognitive function in childhood-onset systemic lupus erythematosus: a pilot study. Arthritis Rheum. 2007;56(12):4151–63.CrossRef DiFrancesco MW, Holland SK, Ris MD, Adler CM, Nelson S, DelBello MP, Altaye M, Brunner HI. Functional magnetic resonance imaging assessment of cognitive function in childhood-onset systemic lupus erythematosus: a pilot study. Arthritis Rheum. 2007;56(12):4151–63.CrossRef
14.
go back to reference Ross GS, Zelko F, Klein-Gitelman M, Levy DM, Muscal E, Schanberg LE, Anthony K, Brunner HI. A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010;62(7):1029–33.CrossRef Ross GS, Zelko F, Klein-Gitelman M, Levy DM, Muscal E, Schanberg LE, Anthony K, Brunner HI. A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010;62(7):1029–33.CrossRef
15.
go back to reference Gitelman DR, Klein-Gitelman MS, Ying J, Sagcal-Gironella AC, Zelko F, Beebe DW, Difrancesco M, Parrish T, Hummel J, Beckwith T, Brunner HI. Brain morphometric changes associated with childhood-onset systemic lupus erythematosus and neurocognitive deficit. Arthritis Rheum. 2013;65(8):2190–200.CrossRef Gitelman DR, Klein-Gitelman MS, Ying J, Sagcal-Gironella AC, Zelko F, Beebe DW, Difrancesco M, Parrish T, Hummel J, Beckwith T, Brunner HI. Brain morphometric changes associated with childhood-onset systemic lupus erythematosus and neurocognitive deficit. Arthritis Rheum. 2013;65(8):2190–200.CrossRef
16.
go back to reference Mugler JP 3rd, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med. 1990;15(1):152–7.CrossRef Mugler JP 3rd, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med. 1990;15(1):152–7.CrossRef
19.
go back to reference Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26(3):839–51.CrossRef Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26(3):839–51.CrossRef
20.
go back to reference Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497–505.CrossRef Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497–505.CrossRef
21.
go back to reference Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161(2):401–7.CrossRef Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161(2):401–7.CrossRef
22.
go back to reference Nichols T, Hayasaka S. Controlling the familywise error rate in functional neuroimaging: a comparative review. Stat Methods Med Res. 2003;12(5):419–46.CrossRef Nichols T, Hayasaka S. Controlling the familywise error rate in functional neuroimaging: a comparative review. Stat Methods Med Res. 2003;12(5):419–46.CrossRef
23.
go back to reference Gasparovic CM, Roldan CA, Sibbitt WL Jr, Qualls CR, Mullins PG, Sharrar JM, Yamamoto JJ, Bockholt HJ. Elevated cerebral blood flow and volume in systemic lupus measured by dynamic susceptibility contrast magnetic resonance imaging. J Rheumatol. 2010;37(9):1834–43.CrossRef Gasparovic CM, Roldan CA, Sibbitt WL Jr, Qualls CR, Mullins PG, Sharrar JM, Yamamoto JJ, Bockholt HJ. Elevated cerebral blood flow and volume in systemic lupus measured by dynamic susceptibility contrast magnetic resonance imaging. J Rheumatol. 2010;37(9):1834–43.CrossRef
24.
go back to reference Huang WS, Chiu PY, Tsai CH, Kao A, Lee CC. Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99m ECD brain SPECT. Rheumatol Int. 2002;22(5):178–81.CrossRef Huang WS, Chiu PY, Tsai CH, Kao A, Lee CC. Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99m ECD brain SPECT. Rheumatol Int. 2002;22(5):178–81.CrossRef
25.
go back to reference Oda K, Matsushima E, Okubo Y, Ohta K, Murata Y, Koike R, Miyasaka N, Kato M. Abnormal regional cerebral blood flow in systemic lupus erythematosus patients with psychiatric symptoms. J Clin Psychiatry. 2005;66(7):907–13.CrossRef Oda K, Matsushima E, Okubo Y, Ohta K, Murata Y, Koike R, Miyasaka N, Kato M. Abnormal regional cerebral blood flow in systemic lupus erythematosus patients with psychiatric symptoms. J Clin Psychiatry. 2005;66(7):907–13.CrossRef
26.
go back to reference Gasparovic C, Qualls C, Greene ER, Sibbitt WL Jr, Roldan CA. Blood pressure and vascular dysfunction underlie elevated cerebral blood flow in systemic lupus erythematosus. J Rheumatol. 2012;39(4):752–8.CrossRef Gasparovic C, Qualls C, Greene ER, Sibbitt WL Jr, Roldan CA. Blood pressure and vascular dysfunction underlie elevated cerebral blood flow in systemic lupus erythematosus. J Rheumatol. 2012;39(4):752–8.CrossRef
27.
go back to reference Greene ER, Yonan KA, Sharrar JM, Sibbitt WL Jr, Roldan CA. Middle cerebral artery resistivity and pulsatility indices in systemic lupus erythematosus: evidence for hyperperfusion. Lupus. 2012;21(4):380–5.CrossRef Greene ER, Yonan KA, Sharrar JM, Sibbitt WL Jr, Roldan CA. Middle cerebral artery resistivity and pulsatility indices in systemic lupus erythematosus: evidence for hyperperfusion. Lupus. 2012;21(4):380–5.CrossRef
28.
go back to reference Savoiardo M. The vascular territories of the carotid and vertebrobasilar systems. Diagrams based on CT studies of infarcts. Ital J Neurol Sci. 1986;7(4):405–9.CrossRef Savoiardo M. The vascular territories of the carotid and vertebrobasilar systems. Diagrams based on CT studies of infarcts. Ital J Neurol Sci. 1986;7(4):405–9.CrossRef
29.
go back to reference Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain. Neurology. 1998;50:1699–708.CrossRef Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain. Neurology. 1998;50:1699–708.CrossRef
30.
go back to reference Kapasi A, Leurgans SE, James BD, Boyle PA, Arvanitakis Z, Nag S, Bennett DA, Buchman AS, Schneider JA. Watershed microinfarct pathology and cognition in older persons. Neurobiol Aging. 2018;70:10–7.CrossRef Kapasi A, Leurgans SE, James BD, Boyle PA, Arvanitakis Z, Nag S, Bennett DA, Buchman AS, Schneider JA. Watershed microinfarct pathology and cognition in older persons. Neurobiol Aging. 2018;70:10–7.CrossRef
31.
go back to reference Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28(7):1320–7.CrossRef Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28(7):1320–7.CrossRef
32.
go back to reference Hugonnet E, Da Ines D, Boby H, Claise B, Petitcolin V, Lannareix V, Garcier JM. Posterior reversible encephalopathy syndrome (PRES): features on CT and MR imaging. Diagn Interv Imaging. 2013;94(1):45–52.CrossRef Hugonnet E, Da Ines D, Boby H, Claise B, Petitcolin V, Lannareix V, Garcier JM. Posterior reversible encephalopathy syndrome (PRES): features on CT and MR imaging. Diagn Interv Imaging. 2013;94(1):45–52.CrossRef
33.
go back to reference Hwang M, Tudorascu DL, Nunley K, Karim H, Aizenstein HJ, Orchard TJ, Rosano C. Brain activation and psychomotor speed in middle-aged patients with type 1 diabetes: relationships with hyperglycemia and brain small vessel disease. J Diabetes Research. 2016;2016:1–11.CrossRef Hwang M, Tudorascu DL, Nunley K, Karim H, Aizenstein HJ, Orchard TJ, Rosano C. Brain activation and psychomotor speed in middle-aged patients with type 1 diabetes: relationships with hyperglycemia and brain small vessel disease. J Diabetes Research. 2016;2016:1–11.CrossRef
34.
go back to reference Liberg B, Adler M, Jonsson T, Landen M, Rahm C, Wahlund LO, Wiberg-Kristoffersen M, Wahlund B. Motor imagery in bipolar depression with slowed movement. J Nerv Ment Dis. 2013;201(10):885–93.CrossRef Liberg B, Adler M, Jonsson T, Landen M, Rahm C, Wahlund LO, Wiberg-Kristoffersen M, Wahlund B. Motor imagery in bipolar depression with slowed movement. J Nerv Ment Dis. 2013;201(10):885–93.CrossRef
35.
go back to reference Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2008;58(4):1130–5.CrossRef Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2008;58(4):1130–5.CrossRef
36.
go back to reference Wang JY, Zhao YH, Zhang JH, Lei HW. Anti-N-methyl-D-aspartic acid receptor 2 (anti-NR2) antibody in neuropsychiatric lupus serum damages the blood-brain barrier and enters the brain. Med Sci Monit. 2019;25:532–9.CrossRef Wang JY, Zhao YH, Zhang JH, Lei HW. Anti-N-methyl-D-aspartic acid receptor 2 (anti-NR2) antibody in neuropsychiatric lupus serum damages the blood-brain barrier and enters the brain. Med Sci Monit. 2019;25:532–9.CrossRef
37.
go back to reference Bravo-Zehnder M, Toledo EM, Segovia-Miranda F, Serrano FG, Benito MJ, Metz C, Retamal C, Alvarez A, Massardo L, Inestrosa NC, Gonzalez A. Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice. Arthritis Rheumatol. 2015;67(1):204–14.CrossRef Bravo-Zehnder M, Toledo EM, Segovia-Miranda F, Serrano FG, Benito MJ, Metz C, Retamal C, Alvarez A, Massardo L, Inestrosa NC, Gonzalez A. Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice. Arthritis Rheumatol. 2015;67(1):204–14.CrossRef
38.
go back to reference Gonzalez A, Massardo L. Antibodies and the brain: antiribosomal P protein antibody and the clinical effects in patients with systemic lupus erythematosus. Curr Opin Neurol. 2018;31(3):300–5.CrossRef Gonzalez A, Massardo L. Antibodies and the brain: antiribosomal P protein antibody and the clinical effects in patients with systemic lupus erythematosus. Curr Opin Neurol. 2018;31(3):300–5.CrossRef
39.
go back to reference Massardo L, Bravo-Zehnder M, Calderón J, Flores P, Padilla O, Aguirre JM, Scoriels L, González A. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus. Lupus. 2015;24(6):558–68.CrossRef Massardo L, Bravo-Zehnder M, Calderón J, Flores P, Padilla O, Aguirre JM, Scoriels L, González A. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus. Lupus. 2015;24(6):558–68.CrossRef
Metadata
Title
Cerebral microvascular and microstructural integrity is regionally altered in patients with systemic lupus erythematosus
Authors
Mark W. DiFrancesco
Gregory Lee
Mekibib Altaye
Dean W. Beebe
Jamie Meyers-Eaton
Hermine I. Brunner
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2020
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-020-02227-7

Other articles of this Issue 1/2020

Arthritis Research & Therapy 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.